According to Deutschlandfunk, Peter Spork is considered "one of the leading German science authors". He studied biology, anthropology and psychology and completed his doctorate in the field of neurobiology/biocybernetics.

Since 1991, he has worked as science journalist and appears as a speaker as well as on TV and radio. Spork has also written several non-fiction books that have been translated into ten languages. In his work on chronobiology and sleep research - for example in the books “Das Schlafbuch” and “Wake up!” - Spork argues for a more well-rested society and searches for the biological causes of sleep.

Dave Coghill is the Financial Markets Foundation Chair of Developmental Mental Health at the University of Melbourne. His research focuses on increasing understanding of child and adolescent mental health using a range of approaches including longitudinal observational studies and big data approaches, neuropsychopharmacology, clinical trials, pharmacoepidemiology and patient reported outcomes.

He has maintained a strong clinical presence developing clinical pathways that facilitate the rapid transfer of research evidence into routine clinical practice. His clinical work is split between the Royal Children’s Hospital and Orygen.

Prof. Dr. rer. medic. Anja Görtz‐Dorten, Dipl.‐Psych., Dipl.‐Heilpäd.

Graduation in special education (Dipl.-Heilpäd.) 1994 (University of Applied Sciences Cologne); license in Child and Adolescent Psychotherapy, 1999; graduation in Psychology (Dipl.-Psych.) 2000 (University Düsseldorf); PhD 2005 (University of Cologne); Habilitation 2014 (University of Cologne); adjunct Professor at the Medical Faculty and the Faculty of Human Sciences of the University of Cologne 2019; Head of the outpatient clinic and the research department at the Center for Child and Adolescent Cognitive Behavior Therapy (CeKiP) and Supervisor in Cognitive Behavior Therapy.

Member of the German Conduct Disorders Guidelines Group.

Research in development and evaluation of assessment instruments of mental disorders and personalized modular cognitive-behavioral treatment programs including digitally supported assessment and intervention for children and adolescents with mental disorders.

Emily Simonoff MD, FRCPsych
Professor of Child and Adolescent Psychiatry & Head of Department Director, King’s Maudsley Partnership for Children and Young People King’s College London, Institute of Psychiatry, Psychology and Neuroscience

Emily Simonoff is Professor of Child and Adolescent Psychiatry at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London, where she is also head of the Department and Director of the King’s Maudsley Partnership for Children and Young People. She is also academic lead for the Child and Adolescent Mental Health Services Clinical Academic Group at the South London and Maudsley Foundation Trust. Emily’s research and clinical focus is on neurodevelopmental disorders in children and young people and their overlap with other mental disorders. She is a UK National Institute of Health Research Senior Investigator. She was the Senior Clinical Advisor to the National Institute of Health and Clinical Excellence (NICE) on the 2018 ADHD guidelines and was a member of the ICHOM Standard Set for Neurodevelopmental Disorders Advisory Group. She chaired the European ADHD Guidelines Group from 2014 to 2022/ Emily’s interests span a range of neurodevelopmental disorders. She has also been a member of the two NICE Guidelines groups for autism and a member of the Strategy Board for the UK National Autism Project. She has been a member of the Westminster Commission for Autism and has given evidence to the All-Party Parliamentary Group on Autism. Emily receives research funding related to autism from the Medical Research Council, Economic and Social Research Council, National Institute of Health and Research EU Innovative Medicines Initiative, amongst other organization. She is a consultant child and adolescent psychiatrist in the Maudsley-based Service for Complex Autism and Associated Neurodevelopmental Disorders, funded by NHS England to see children and young people across the southern region with complex presentations.

Professor emeritus of Psychotherapy at the Department of Child and Adolescent Psychiatry, Psychosomatic and Psychotherapy, Medical Faculty
and Faculty of Human Sciences of the University of Cologne, Germany.

Professor Dr. Doepfner began his career with a Psychology degree at the University of Mannheim. Germany. In 1990, he received his doctorship from the University of Heidelberg’s Faculty of Medicine. He is supervisor of behaviour therapy and Head of the School or Child and Adolescent Cognitive Behavior Therapy (AKiP) at the University of Cologne. He received the German Psychology Prize for his scientific work in 2005.

His main research interests are assessment, prevention, and treatment of ADHD, Conduct Disorders, Anxiety Disorders, Obsessive-Compulsive Disorders and Tic Disorders. He is principal investigator of several multicentre trials on pharmacotherapy and psychotherapy of ADHD and conduct disorders, of prevention studies for externalizing problem behaviour in children, and on self-help-interventions for parents of children and adolescents with ADHD/ODD.

Prof. em. Manfred Doepfner, PhD
Department for Child and Adolescent Psychiatry, Psychosomatic and Psychotherapy
School for Child and Adolescent Cognitve Behavior Therapy
University of Cologne
Pohligstr. 9, D-50969 Koeln, Germany
manfred.doepfner@uk-koeln.de
 

Diane Purper-Ouakil is professor of child and adolescent psychiatry at the university hospital of Montpellier, France. Since 2011, she is head of the child and adolescent unit of the Saint Eloi Hospital. This unit has facilities for both inpatient and outpatient care for young patients and has specialized services for children and adolescents with ADHD and eating disorders.
She is also vice-president of the faculty college of psychiatry involved in the ongoing reform of the training curriculum of medical studies and is member of the professional college of psychiatrists. 
Diane Purper-Ouakil aims to develop the evidence-base of psychological, neurophysiological and pharmacological treatments, especially for children and adolescents with challenging and enduring behavioural and emotional symptoms. She is involved in collaborative treatment studies, some assessing parent programs, an important feature of comprehensive treatment plans for young people with complex needs.